Rockville, MD, United States of America

Brian R De Costa


Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 83(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1992 - 1998)
  • Rockville, MD (US) (1994 - 2003)

Company Filing History:


Years Active: 1992-2003

Loading Chart...
14 patents (USPTO):

Title: Brian R. de Costa: Innovator in CNS Disorder Treatments

Introduction

Brian R. de Costa is a distinguished inventor based in Rockville, Maryland, who has made significant contributions to the field of pharmaceuticals through his innovative research. With a remarkable portfolio of 14 patents, de Costa has focused on developing treatments for central nervous system (CNS) disorders, paving the way for potential breakthroughs in medical science.

Latest Patents

One of Brian R. de Costa's latest patents involves aralkyl diazabicycloalkane derivatives, aimed at treating various CNS disorders such as cerebral ischemia, psychosis, and convulsions. These compounds have shown promise in their ability to mitigate symptoms associated with these serious conditions, demonstrating de Costa's commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Throughout his career, de Costa has collaborated with prominent organizations, including the United States of America as represented by the Department of Health and Pharmaceutical Discovery Corporation. His work has not only advanced scientific knowledge but also contributed to public health initiatives aimed at improving the lives of individuals suffering from CNS disorders.

Collaborations

Brian R. de Costa has had the opportunity to work alongside esteemed colleagues, including Kenner C. Rice and Wayne D. Bowen. These collaborations have facilitated the exchange of ideas and expertise, enhancing the impact of their collective research efforts in developing pharmaceutical innovations.

Conclusion

In summary, Brian R. de Costa stands out as an influential inventor dedicated to addressing CNS disorders through his innovative work. His extensive patent portfolio and collaborations with leading institutions underscore his role as a key player in the field of pharmaceutical advancements, offering hope for better treatments and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…